Chinese regulators are tightening scrutiny of humanoid robot IPOs after Unitree Robotics’ shares fell about 55% from their peak, raising questions about whether valuations in the fast-growing sector are supported by commercial demand. Reuters reported that authorities have used informal guidance to raise the bar for prospective listings, rather than imposing a formal sectorwide ban.

The scrutiny follows an unusually volatile debut for Unitree, which listed on the Shanghai Stock Exchange’s STAR Market in August. Its shares initially surged more than sixfold, briefly giving the company a valuation of about $67 billion, before the subsequent decline. The retail portion of its IPO was oversubscribed more than 8,000 times. Reuters reported on Unitree’s IPO debut and investor demand

Unitree’s revenue increased to nearly 1.7 billion yuan ($252 million) in 2025, up from 392.77 million yuan in the previous year, as stated in the IPO filing. However, the share price implied a valuation of more than 219 times its 2025 earnings and 36 times revenue. Reuters’ report on Unitree’s IPO valuation and financial results

Regulators are also examining how much of the sector’s reported business is tied to government-backed projects. Reuters reported that local governments fund 80% to 90% of some robot data centers and joint ventures. One investor source told Reuters that some companies’ valuations could fall 60% to 70% if revenue linked to those facilities were excluded. That estimate is an analyst or investor assessment, not an official regulatory valuation. Reuters report on China's humanoid robot IPO scrutiny

The concerns come while humanoid robotics remains a small market compared with conventional industrial automation. The International Federation of Robotics noted that there were 542,000 industrial robots in operation around the world in 2024. It is worth noting that the figures of about 7,000 humanoid robots reported recently for 2025 are not directly comparable because the years and robot classifications differ.

Optimus humanoid by Tesla has a completely different direction. The company said its first production line was being prepared, with production planned before the end of 2026. Tesla’s 2025 annual filing Tesla has not announced a general consumer launch date or commercial availability for Optimus.

The regulatory shift leaves prospective Chinese humanoid listings facing closer scrutiny of revenue quality, commercial orders and the extent to which government-supported projects contribute to reported growth.